CoChat

Gene Therapy of Canavan Disease: AAV-2 Vector for Neurosurgical Delivery of Aspartoacylase Gene ( ASPA ) to the Human Brain

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Abstract

This clinical protocol describes virus-based gene transfer for Canavan disease, a childhood leukodystrophy. Canavan disease, also known as Van Bogaert-Bertrand disease, is a monogeneic, autosomal recessive disease in which the gene coding for the enzyme aspartoacylase (ASPA) is defective. The lack of functional enzyme leads to an increase in the central nervous system of the substrate molecule, N-acetyl-aspartate (NAA), which impairs normal myelination and results in spongiform degeneration of the brain. No effective treatment currently exists; however, virus-based gene transfer has the potential to arrest or reverse the course of this otherwise fatal condition. This procedure involves neurosurgical administration of approximately 900 billion genomic particles (approximately 10 billion infectious particles) of recombinant adeno-associated virus (AAV) containing the aspartoacylase gene (ASPA) directly to affected regions of the brain in each of 21 patients with Canavan disease. Pre- and post-delivery assessments include a battery of noninvasive biochemical, radiological, and neurological tests. This gene transfer study represents the first clinical use of AAV in the human brain and the first instance of viral gene transfer for a neurodegenerative disease.

Overview

Integrity signals

Registry

Crossref · 10.1089/104303402760128612

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 55 references

Research works printed but not linked: 6

  1. LEONE P., 1999, Curr. Opin. Mol. Ther., 1, 487
  2. 10.1002/ana.102 · doi:10.1002/ana.102
  3. 10.1002/(SICI)1521-2254(200005/06)2:3<165::AID-JGM107>3.3.CO;2-I · doi:10.1002/(sici)1521-2254(200005/06)2:3<165::aid-jgm107>3.3.co;2-i
  4. STEEN R.G., 1997, Am. J. Neuroradiol., 18, 819
  5. WANG Z.J., 1998, Neuroimaging Clin. N. Am., 8, 781
  6. ZELNIK N., 1994, Dev. Med. Child. Neurol., 36, 845

Cited by

See all 255

Metadata

Authors
Janson, C., McPhee, S., Bilaniuk, L., Haselgrove, J., Testaiuti, M., Freese, A., Wang, D.-J., Shera, D., Hurh, P., Rupin, J., Saslow, E., Goldfarb, O., Goldberg, M., Larijani, G., Sharrar, W., Liouterman, L., Camp, A., Kolodny, E., Samulski, J., & Leone, P.
Affiliations
  • Robert Wood Johnson Medical School-UMDNJ and Cooper Hospital
  • University of North Carolina at Chapel Hill (US)
  • Children's Hospital of Philadelphia (US)
Venue
Human Gene Therapy
Published
2002-07-20
Volume
13
Issue
11
Pages
1391-1412
ISSN
  • 1043-0342 (ISSN-L)
  • 1557-7422
OpenAlex
W2153042097
Cited by
255
References
54
Citations by year
2026: 2 · 2025: 5 · 2024: 15 · 2023: 11 · 2022: 3 · 2021: 7 · 2020: 10 · 2019: 6 · 2018: 7 · 2017: 6 · 2016: 13 · 2015: 7 · 2014: 11 · 2013: 12 · 2012: 13
FWCI
9.82
Type
journal article
Language
en
Open access
closed
Licence
www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/ (tdm)
Locations
  • Human Gene Therapy (publishedVersion)
  • PubMed (publishedVersion)
  • DigitalGeorgetown (Georgetown University Library) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Keywords
Canavan disease, aspartoacylase, gene therapy, leukodystrophy, N-acetylaspartate, myelination, neurodegenerative diseases, recombinant adeno-associated virus, substrate accumulation
MeSH terms
Dependovirus, Amidohydrolases, Brain, Child, Preschool, Clinical Protocols, Clinical Trials as Topic, Female, Follow-Up Studies, Genetic Vectors, Humans, Infant, Injections, Intraventricular, Magnetic Resonance Imaging, Male, Magnetic Resonance Spectroscopy, Genetic Therapy, Cohort Studies, Canavan Disease, Gene Transfer Techniques, Patient Selection

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gene Therapy of Canavan Disease: AAV-2 Vector for Neurosurgical Delivery of Aspartoacylase Gene ( ASPA ) to the Human Brain. https://app.cochat.ai/papers/10.1089/104303402760128612
The paper
Janson, C., McPhee, S., Bilaniuk, L., Haselgrove, J., Testaiuti, M., Freese, A., Wang, D.-J., Shera, D., Hurh, P., Rupin, J., Saslow, E., Goldfarb, O., Goldberg, M., Larijani, G., Sharrar, W., Liouterman, L., Camp, A., Kolodny, E., Samulski, J., & Leone, P. (2002). Gene Therapy of Canavan Disease: AAV-2 Vector for Neurosurgical Delivery of Aspartoacylase Gene ( ASPA ) to the Human Brain. Human Gene Therapy. https://doi.org/10.1089/104303402760128612

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.